Dr Reddys Laboratories (RDY) Intangibles (2009 - 2026)

Dr Reddys Laboratories has reported Intangibles for 18 years, with the latest figure at $1.1 billion in Q2 2026.

• On a quarterly basis, Intangibles fell 2.03% year-over-year to $1.1 billion in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 2.03% decrease from a year earlier, with the FY2026 full-year figure at $1.1 billion, down 1.23% from the prior year.
• Intangibles was $1.1 billion for Q2 2026 at Dr Reddys Laboratories, down from $1.1 billion in the prior quarter.
• The five-year high for Intangibles was $1.2 billion in Q3 2025, with the low at $362.3 million in Q1 2022.
• Average Intangibles over 5 years is $730.8 million, with a median of $455.8 million recorded in 2023.
• The sharpest annual moves came in 2022 and 2025: Intangibles slipped 25.89% in 2022, then soared 151.24% in 2025.
• Over 5 years, Intangibles stood at $376.4 million in 2022, then advanced by 17.74% to $443.2 million in 2023, then jumped by 148.31% to $1.1 billion in 2024, then grew by 4.4% to $1.1 billion in 2025, then fell by 4.75% to $1.1 billion in 2026.
• The last three Intangibles figures came in at $1.1 billion (Q2 2026), $1.1 billion (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.